Skip to content

Cannabis: all studies

Page 234 of 288: studies 2,331 to 2,340 of 2,874, newest first. Back to the cannabis overview

Research

Who uses digital drugs? An international survey of 'binaural beat' consumers.

Drug and Alcohol Review July 1, 2022 Monica J Barratt, Alexia Maddox, Naomi Smith et al. 19 citations

Digital drugs, or binaural beats claimed to elicit specific cognitive or emotional states, are a phenomenon about which little is known. In this brief report, we describe demographic and drug use correlates of binaural beat use, patterns of use, reasons for use and methods of access. The Global Drug Survey 2021 was translated into 11 languages; 30 896 responses were gathered from 22 countries....

DOI: 10.1111/dar.13464 (opens in new tab) Full text (opens in new tab) Cross-sectional study Hallucinogen Illicit drug Music +1

Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research

Addiction Neuroscience June 22, 2022 Fúlvio Rieli Mendes, Cristiane Dos Santos Costa, Victor Distefano Wiltenburg et al. 55 citations

Substance use disorder (SUD) is a global public health concern that affects millions of people worldwide. Considering current research, addiction has been noted as the last stage of a chronic disease that may impair brain reward circuit responses and affects personal and social life. Treatments for SUD face challenges including availability and limited pharmacological response, often resulting...

0841 Case Report: Can LSD be Associated with Chronic Exploding Head Syndrome?

Sleep May 25, 2022 Feby Puravath Manikat, Clete A. Kushida

Abstract Introduction Exploding head syndrome is a rare phenomenon characterized by a loud imagined noise at sleep onset. Less commonly, it is associated with a simultaneous stab of pain in the forehead. It may result in recurring arousals and anxiety regarding the events. The underlying pathophysiology remains unknown. Report of Cases: A 27 year old male with no past medical history presented...

Views on Using Psychoactive Substances to Self-Manage Functional Neurological Disorder: Online Patient Survey Results

The Journal of Neuropsychiatry and Clinical Neurosciences May 17, 2022 Matthew Butler, Mathieu Seynaeve, Abigail Bradley‐Westguard et al. 6 citations

Objective: Functional neurological disorder (FND) causes a high burden of disability and distress. Although it is a common disorder, there is a pressing need for improved access to evidence-based treatments. With difficulties in finding effective treatment, some people with FND may seek alternative means of symptom relief, such as legal and illicit psychoactive substances, although the...

Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.

Toxicological sciences : an official journal of the Society of Toxicology April 26, 2022 Christian V Cabanlong, Lauren N Russell, William E Fantegrossi et al.

Synthetic cannabinoid receptor agonists (SCRAs) are a large group of abused psychoactive compounds that elicit numerous toxic effects not observed with cannabis, including death. Abuse of third-generation SCRA 5F-MDMB-PINACA (also known as 5F-ADB) has been associated with over 40 fatalities. This SCRA is metabolized to several active phase I metabolites, including excessively high post-mortem...

DOI: 10.1093/toxsci/kfac024 (opens in new tab) Full text (opens in new tab) G-protein coupled receptors Cb1 receptors Metabolites Novel psychoactive substances +2

Psychosocial and Drug Use Assessment of Regular vs. Non-Regular Ayahuasca Users in a Brazilian Sample: a Web-Based Survey

Substance Use & Misuse April 25, 2022 Dimitri Daldegan-Bueno, Dóra Révész, Paulo Rogério Morais et al. 15 citations

Background: Preliminary evidence suggests that long-term ayahuasca use is associated with better psychosocial outcomes and less drug use; however, available data on the association between ayahuasca intake frequency and psychosocial outcomes is limited. Objectives: We sought to characterize and investigate the association of regular ayahuasca use, as compared to non-regular use, on licit...

Cannabinoid use is enhanced by stress and changes conditioned stress responses.

Neuropsychopharmacology April 2022 Ritchy Hodebourg, Michael E Meyerink, Ayteria D Crow et al.

Individuals diagnosed with post-traumatic stress disorder (PTSD) are often comorbid for substance use disorders. Cannabis is widely used by PSTD patients, and the literature is mixed on whether cannabis use ameliorates or exacerbates patient responses to stress-associated conditioned stimuli (stress-CS). We determined if cannabis use affects responsivity to stress-CS in rats receiving 2 h...

Resistance to depth inversion illusions: A biosignature of psychosis with potential utility for monitoring positive symptom emergence and remission in schizophrenia

Biomarkers in Neuropsychiatry March 26, 2022 Samantha I. Fradkin, Steven M. Silverstein 1 citation

The predictive coding theory of psychosis posits that individuals with schizophrenia demonstrate abnormalities in the strength of top-down modulation (based on prior experience) of sensory signals. Evidence suggests that difficulty perceiving depth inversion illusions (DIIs) (i.e., more accurate perception of stimuli under conditions in which control subjects perceive these illusions) may...

DOI: 10.1016/j.bionps.2022.100050 (opens in new tab) Psychosis Biomarker Schizophrenia object-oriented programming Illusion +5

Endocannabinoid system contributions to sex-specific adolescent neurodevelopment.

Progress in Neuro-Psychopharmacology and Biological Psychiatry March 8, 2022 Jonathan J. Simone, Matthew R Green, Cheryl M McCormick

With an increasing number of countries and states adopting legislation permitting the use of cannabis for medical purposes, there is a growing interest among health and research professionals into the system through which cannabinoids principally act, the endocannabinoid system (ECS). Much of the seminal research into the ECS dates back only 30 years and, although there has been tremendous...

DOI: 10.1016/j.pnpbp.2021.110438 (opens in new tab) Full text (opens in new tab) Adolescence Behaviour Cb1 receptor Endocannabinoid +2

Shrines, Drugs, and Mental Health in South Asian Culture: A Case Study of Rahman Baba Shrine, Peshawar Pakistan

Pakistan Journal of Applied Social Sciences March 8, 2022 Shakeel Ahmed, Imran Ahmad Sajid, Samia Shakeel 1 citation

This phenomenological study explores the traits of substance-induced mysticism at the Rehman Baba shrine in Pakistan. The shrine of Rehman Babais frequently visited by many. Some of the Malang(monks) use marijuana to induce a mystic experience. It has become a socially acceptable practice at this shrine. It uses non-participant observation of the substance users and exploratory interviews along...

DOI: 10.46568/pjass.v13i1.612 (opens in new tab) Mysticism Harmony color Humanity Mental health +8